AIDS TREATMENT NEWS Issue #221, April 21, 1995
The last issue of AIDS TREATMENT NEWS gave contact numbers
for information about volunteering for trials of MK-639, the
experimental protease inhibitor developed by Merck and Co.
Since we went to press, the numbers for Canada, Spain, and
Switzerland have changed. All other numbers are the same.
In Canada, call Dr. Dr. Alain Prat, 514/428-2639. In Spain,
call Dr. Jorge Gonzalez Esteban, 34-1-742-6012. In
Switzerland, call Dr. Martin Fenner, 41-1-828-7111.
The other contacts are: in France, Dr. Marc Bratzlavsky, 33-
1-47-54-89-90; in Germany, Dr. Gunter Janhofer, 49-89-45-61-
1104; in the U.S., call the Merck Protease Inhibitor
Information Line, 800/379-1332, between 8 a.m. and 7 p.m.
Eastern time Monday through Friday.